Allarity Therapeutics, Inc. Payments of Stock Issuance Costs
Allarity Therapeutics, Inc. (ALLR) reported Payments of Stock Issuance Costs of $1.24 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2024-03-08
- Allarity Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2023-12-31 was $0.00.
- Allarity Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2023-09-30 was $0.00.
- Allarity Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2021-12-31 was $1.42M, a 2020.90% increase year-over-year.
- Allarity Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2021-09-30 was $499.00K.
- Allarity Therapeutics, Inc. payments of stock issuance costs for fiscal 2023 was $1.24M.
- Allarity Therapeutics, Inc. payments of stock issuance costs for fiscal 2021 was $2.04M, a 815.25% increase from fiscal 2020.
- Allarity Therapeutics, Inc. payments of stock issuance costs for fiscal 2020 was $223.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $0.00 derived: sum of 2 quarters · filed 2024-03-08 | $1.24M 10-K · filed 2024-03-08 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.24M 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $1.24M 10-Q · filed 2023-08-14 | ||||
| 2021-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $1.92M derived: sum of 2 quarters · filed 2023-03-13 | $2.04M 10-K · filed 2023-03-13 | $484.00K 10-K · filed 2022-05-17 | |
| 2021-09-30 | $499.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $620.00K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $121.00K 10-Q · filed 2022-10-07 | ||||
| 2020-12-31 | $67.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-05-17 | $223.00K 10-K · filed 2022-05-17 | |||
| 2020-09-30 | $156.00K 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |